Welcome to ecancermedicalscience, the open access cancer journal founded by the European Institute of Oncology in Milan. With Open Access publishing a reality and an urgent need for improved cancer communications, ecancermedicalscience fits the 21st century bill for a cancer journal. We see the future as free; free to publish, free to read and free to comment.

Thanks to online, multimedia technology and a community poised to podcast and blog - ecancermedicalscience offers a multimedia and multidisciplinary approach to cancer.

Our Mission

European cancer research is of a very high quality but is fragmented, un-coordinated and slow in translating benefits to patients. Cancer care delivery is also excellent in some European countries but by no means all. If state of the art treatment was available to all cancer patients, the World Health Organisation has estimated that over 20,000 lives would be saved annually.

ecancermedicalscience aims to improve communications between sub-specialised cancer scientists and clinicians by working interactively and faster - offering authors a rapid peer review process. Submit your paper and you'll hear if it will be published within three weeks.

ecancermedicalscience actively encourages the communities of sub-specialised scientists and cancer carers to exchange ideas and research, speeding up the time it takes from discovery, to patient benefit.

The facts

ecancermedicalscience (ISSN 1754-6605) is a non-profit, independent, online journal, publishing research articles after full peer review. All articles are published online immediately upon acceptance. The journal is published by Cancer Intelligence Ltd, Westpoint, 78 Queens Road, Clifton, Bristol, BS8 1QU.

ecancermedicalscience is editorially independent of the European Institute of Oncology.

Professor Umberto Veronesi is the Founding Editor of ecancermedicalscience. Professor Gordon McVie is Managing Editor of ecancermedicalscience.

The Sponsors

The founding partners of ecancermedicalscience are The European CanCer Organisation, and The Umberto Veronesi Foundation.

The European Institute of Oncology Foundation and Swiss Bridge are the key founding charities of the journal.

Scope

ecancermedicalscience is a multidisciplinary, peer-reviewed journal that considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials and cancer policy. ecancermedicalscience also publishes case reports.

Criteria for publication

Publication of research articles by ecancermedicalscience is dependent primarily on their validity and coherence, as judged by a peer reviewer. The reviewer is asked how remarkable they consider the article to be. ecancermedicalscience is interested in publishing; innovative studies testing new hypotheses; policy research papers that challenge conventional thinking and case studies that address new and interesting ways of working.

Speed of publication

ecancermedicalscience offers fast publication whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed electronically. A web version, and accompanying PDF, will be published within a few days of acceptance.

Flexibility

As an online-only journal, ecancermedicalscience gives authors the opportunity to publish large datasets, large numbers of illustrations and moving pictures and the opportunity to include all relevant links (for example, to sequence and other databases, and to other papers), that improve the readers experience.

Charges

ecancermedicalscience does not charge for processing or publishing articles. All costs are covered by advertising, sponsorship and grants.

Submission of manuscripts

Manuscripts must be submitted to ecancermedicalscience electronically using the online manuscript submission process. Full details of how to submit a manuscript are given in the instructions for authors.

Indexing and archiving

Following publication in ecancermedicalscience, the full text of each article will be permanently archived within ecancermedicalscience

Impact factor

As a new journal ecancermedicalscience is not yet eligible for an impact factor rating. ecancermedicalscience will calculate an unofficial impact factor based on the same data and methodology that Thompson Scientific use for their official calculations.

Copyright

The author retains copyright, licensing the article under a Creative Commons licence (see below). The article can be redistributed and reused by anyone as long as the article is correctly attributed. For example, the published article can be posted on a personal or institutional website, e-mailed to friends and colleagues, printed and sent to as many people as you wish, archived in a collection, included in coursepacks, distributed on CD-ROMs, quoted in the press, translated and further distributed.

Authors will be asked to agree, by submission, to an exclusive license agreement which states that anyone is free:

To Share: to copy, distribute and transmit the work

Under the following conditions:

Attribution: Work must be attributed to the original author.
Non-commercial: No one may use this work for commercial purposes.
No Derivative Works: The work may not be altered, transformed, or built upon.

For any reuse or distribution, you must make clear to others the license terms of this work. The best way to do this is with a link to this web page Creative Commons Licence 3.0 ND

Statutory fair use and other rights are in no way affected by the above.

Open access

Our Open Access ethos is defined by the Budapest Open Access Initiative (BOAI) 14th February 2002. The statement aims to accelerate progress in the international effort to make research articles in all academic fields freely available on the internet. ecancermedicalscience is free to publish and free to read.

ecancermedicalscience encourages authors to post a copy of the article as accepted for publication after peer-review: on the author's own website, the author's institutional repository, or the author's funding body's archive - immediately after publication in ecancermedicalscience.

Citing papers in the journal

Articles in ecancermedicalscience should be cited in the same way as articles in a traditional journal, with one exception. Articles in this journal are not printed, they do not have page numbers. Instead, they have a Unique Article Number.

The following citation:

ecancermedicalscience 2007, 1:2

refers to article 2 from volume 1 of the journal.

As an online journal, ecancermedicalscience does not have issue numbers. Each volume corresponds to a calendar year.

Contacting ecancermedicalscience

Queries about content, submissions, or the review process should be directed to editor@ecancermedicalscience.com. All other enquiries should be directed to info@ecancermedicalscience.com

call to advertise here +44 (0) 20 8544 1050